|FYE 3/'20||FYE 3/'21||FYE 3/'22 |
|Cardiac and Vascular Company||350.6||328.5||373.5|
|General Hospital Company||171.0||175.5||181.5|
|Blood and Cell Technologies Company||107.2||109.5||115.0|
※Terumo Corporation has adopted IFRS from the fiscal year ended March 31, 2018.
※FY2021 Guidance is disclosed in a range format due to the impact of COVID-19 pandemic.
Bar graph shows the lowest in the range.